Phage Display Technology
Phage Display Technology - Related Videos
12:55
Scalable High Throughput Selection From Phage-displayed Synthetic Antibody Libraries
0 Views •
Cited by 33 •
2015
A method is described with visual accompaniment for conducting scalable, high throughput selections from phage-displayed combinatorial synthetic antibody libraries against hundreds of antigens simultaneously. Using this parallel approach, we have isolated antibody fragments that exhibit high affinity and specificity for diverse antigens that are functional in standard immunoassays.
05:22
Using Phage Display to Select Proteins with High Affinity to a Target Protein
0 Views •
2025
In this video, we demonstrate the phage display technique to isolate pre-engineered phages expressing proteins with high affinity to the target protein.
12:36
A Protocol for Phage Display and Affinity Selection Using Recombinant Protein Baits
0 Views •
Cited by 3 •
2014
Phage display is a powerful technique to capture proteins or protein moieties that interact with an immobilized molecule of interest. Once a decision of the type of phage cDNA library to create and screen has been made, the protocol described here permits efficient affinity selection leading to identification of interactors.
07:53
Peptides from Phage Display Library Modulate Gene Expression in Mesenchymal Cells and Potentiate Osteogenesis in Unicortical Bone Defects
0 Views •
Cited by 3 •
2010
A phage display library was used to identify peptide sequences that target bone. The objective was to investigate the effect of these peptides on mesenchymal cell differentiation and to determine their effect on bone regeneration.
10:52
Precise Phage Mutagenesis with NgTET-Assisted CRISPR-Cas Systems
0 Views •
2025
Here, we present a protocol to reduce DNA modifications in bacteriophages using the NgTET enzyme, enabling efficient and scarless CRISPR-Cas mutagenesis. This method facilitates the genetic engineering of phages for applications in biotechnology and phage therapy.
FAQs
The displayed peptide or protein provides the measurable binding property, while the phage carries the DNA sequence that encodes it. After a binding phage is recovered, its internal genetic information identifies the molecule responsible for recognition. This direct connection allows researchers to move from a selected binding event to the corresponding sequence for further study or engineering.
The phage surface presents peptides, antibody fragments, or proteins where they can interact with an immobilized target. Its internal DNA preserves the identity of the displayed molecule during recovery and amplification. Maintaining both features in one biological particle makes it possible to select molecules based on binding while retaining the information needed to identify them.
Repeated cycles increase the representation of phages that bind the chosen target. In each cycle, a library is exposed to the immobilized target, bound particles are recovered, and the recovered phages are amplified in bacteria before another selection round. This repeated process progressively enriches binding molecules, making them easier to identify from the population.
Immobilizing the target creates a defined surface for exposing the phage library and separating retained particles from those that do not bind under the selection conditions. The recovered phages therefore reflect interactions with that target in the screening setup. This arrangement supports the identification of molecules involved in molecular recognition and can contribute to epitope mapping.
A typical workflow begins by exposing a genetically engineered phage library to an immobilized target. Phages that bind are recovered, introduced into bacteria for amplification, and then used in additional selection cycles. The enriched population can subsequently be examined through its carried DNA sequences, linking the observed binding activity with the corresponding peptide, protein, or antibody fragment.
The method is useful when researchers need to identify antibody fragments or other proteins that recognize a selected target. Because binding molecules can be enriched and their encoding sequences recovered, candidates can also support protein engineering studies. These capabilities make phage display relevant to developing research reagents and investigating how molecular recognition can be modified.
Selected peptides or antibody fragments can reveal which molecular regions participate in recognition, supporting epitope mapping. The same discovery framework can generate binding molecules for research reagents and diagnostics, while identified binders may also inform potential therapeutic development. In biology, the approach connects sequence information with protein or peptide recognition across these applications.